| RS2108873176 |
TP63
|
Health Risk |
Likely pathogenic |
TP63-Related Spectrum Disorders, TP63-Related Spectrum Disorders |
| RS2108873431 |
TP63
|
Health Risk |
Pathogenic |
Rapp-Hodgkin syndrome, Rapp-Hodgkin syndrome |
| RS2108874029 |
TP63
|
Health Risk |
Pathogenic |
Rapp-Hodgkin syndrome, Rapp-Hodgkin syndrome |
| RS2108874622 |
TP63
|
Health Risk |
Likely pathogenic |
TP63-Related Spectrum Disorders, TP63-Related Spectrum Disorders |
| RS2108874645 |
TP63
|
Health Risk |
Pathogenic |
Rapp-Hodgkin syndrome, Rapp-Hodgkin syndrome |
| RS2108877068 |
NSD2
|
Health Risk |
Pathogenic |
Rauch-Steindl syndrome, Rauch-Steindl syndrome |
| RS2108881184 |
MYLK
|
Health Risk |
Likely pathogenic |
— |
| RS2108889206 |
OPA1
|
Health Risk |
Pathogenic |
— |
| RS2108895910 |
EVC2
|
Health Risk |
Pathogenic |
Ellis-van Creveld syndrome, Curry-Hall syndrome |
| RS2108900159 |
EVC2
|
Health Risk |
Pathogenic/Likely pathogenic |
Ellis-van Creveld syndrome, Curry-Hall syndrome |
| RS2108907946 |
TAPT1
|
Health Risk |
Likely pathogenic |
— |
| RS2108908334 |
P3H2
|
Health Risk |
Pathogenic |
Myopia, high |
| RS2108909805 |
P3H2
|
Health Risk |
Pathogenic |
— |
| RS2108910327 |
P3H2
|
Health Risk |
Pathogenic |
— |
| RS2108914971 |
ATP2C1
|
Health Risk |
Pathogenic |
— |
| RS2108940028 |
PIGG
|
Health Risk |
Pathogenic |
Intellectual disability, autosomal recessive 53 |
| RS2108940433 |
NSD2
|
Health Risk |
Pathogenic |
Rauch-Steindl syndrome, Rauch-Steindl syndrome |
| RS2108949204 |
PIGG
|
Health Risk |
Pathogenic |
Intellectual disability, autosomal recessive 53 |
| RS2108950399 |
NSD2
|
Health Risk |
Likely pathogenic |
Rauch-Steindl syndrome, Rauch-Steindl syndrome |
| RS2108957092 |
NSD2
|
Health Risk |
Pathogenic |
— |
| RS2108958731 |
NSD2
|
Health Risk |
Likely pathogenic |
Wolf-Hirschhorn like syndrome, Wolf-Hirschhorn like syndrome |
| RS2108959336 |
NSD2
|
Health Risk |
Pathogenic |
Rauch-Steindl syndrome, Rauch-Steindl syndrome |
| RS2108966214 |
PIGG
|
Health Risk |
Pathogenic |
Intellectual disability, autosomal recessive 53 |
| RS2108968160 |
PIGG
|
Health Risk |
Pathogenic |
Intellectual disability, autosomal recessive 53 |
| RS2108969826 |
PIGG
|
Health Risk |
Likely pathogenic |
Intellectual disability, autosomal recessive 53 |
| RS2108970120 |
CC2D2A
|
Health Risk |
Pathogenic/Likely pathogenic |
Meckel-Gruber syndrome, Joubert syndrome |
| RS2108971327 |
NSD2
|
Health Risk |
Pathogenic |
Rauch-Steindl syndrome, Rauch-Steindl syndrome |
| RS2108971782 |
NSD2
|
Health Risk |
Pathogenic |
4p partial monosomy syndrome, 4p partial monosomy syndrome |
| RS2108976771 |
NSD2
|
Health Risk |
Likely pathogenic |
Rauch-Steindl syndrome, Rauch-Steindl syndrome |
| RS2108977238 |
RAB28
|
Health Risk |
Pathogenic |
— |
| RS2108979504 |
OPA1
|
Health Risk |
Pathogenic |
— |
| RS2108982050 |
RAB28
|
Health Risk |
Likely pathogenic |
— |
| RS2108987681 |
QDPR
|
Health Risk |
Pathogenic |
Dihydropteridine reductase deficiency, Dihydropteridine reductase deficiency |
| RS2108987721 |
QDPR
|
Health Risk |
Pathogenic |
— |
| RS2108987974 |
QDPR
|
Health Risk |
Pathogenic |
Dihydropteridine reductase deficiency, Dihydropteridine reductase deficiency |
| RS2108992958 |
QDPR
|
Health Risk |
Pathogenic |
Dihydropteridine reductase deficiency, Dihydropteridine reductase deficiency |
| RS2108993008 |
QDPR
|
Health Risk |
Pathogenic |
Dihydropteridine reductase deficiency, Dihydropteridine reductase deficiency |
| RS2108995799 |
PIGG
|
Health Risk |
Pathogenic/Likely pathogenic |
Intellectual disability, autosomal recessive 53 |
| RS2108997263 |
QDPR
|
Health Risk |
Pathogenic |
Dihydropteridine reductase deficiency, Dihydropteridine reductase deficiency |
| RS2108998253 |
CC2D2A
|
Health Risk |
Likely pathogenic |
Meckel-Gruber syndrome, Joubert syndrome |
| RS2108999089 |
QDPR
|
Health Risk |
Pathogenic |
Dihydropteridine reductase deficiency, Dihydropteridine reductase deficiency |
| RS2109002510 |
OPA1
|
Health Risk |
Likely pathogenic |
— |
| RS2109002680 |
OPA1
|
Health Risk |
Pathogenic |
— |
| RS2109005483 |
EIF2B5
|
Health Risk |
Likely pathogenic |
— |
| RS2109005842 |
NKX3-2
|
Health Risk |
Likely pathogenic |
Connective tissue disorder, Connective tissue disorder |
| RS2109007324 |
EIF2B5
|
Health Risk |
Pathogenic |
— |
| RS2109008895 |
EIF2B5
|
Health Risk |
Likely pathogenic |
See cases, See cases |
| RS2109009235 |
EIF2B5
|
Health Risk |
Pathogenic |
— |
| RS2109010145 |
EIF2B5
|
Health Risk |
Pathogenic |
— |
| RS2109010154 |
EIF2B5
|
Health Risk |
Pathogenic |
— |
| RS2109010667 |
EIF2B5
|
Health Risk |
Pathogenic |
— |
| RS2109010735 |
EIF2B5
|
Health Risk |
Pathogenic |
— |
| RS2109010897 |
EIF2B5
|
Health Risk |
Pathogenic |
— |
| RS2109010973 |
EIF2B5
|
Health Risk |
Likely pathogenic |
— |
| RS2109011385 |
OPA1
|
Health Risk |
Likely pathogenic |
Optic atrophy with or without deafness, ophthalmoplegia |
| RS2109011461 |
OPA1
|
Health Risk |
Pathogenic |
— |
| RS2109012187 |
EIF2B5
|
Health Risk |
Likely pathogenic |
Vanishing white matter disease, Vanishing white matter disease |
| RS2109012834 |
CC2D2A
|
Health Risk |
Pathogenic |
Joubert syndrome, Meckel-Gruber syndrome |
| RS2109014867 |
OPA1
|
Health Risk |
Likely pathogenic |
— |
| RS2109014902 |
OPA1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS2109015193 |
OPA1
|
Health Risk |
Likely pathogenic |
Optic atrophy with or without deafness, ophthalmoplegia |
| RS2109020378 |
NSD2
|
Health Risk |
Pathogenic/Likely pathogenic |
Rauch-Steindl syndrome, NSD2-related disorder |
| RS2109020533 |
NSD2
|
Health Risk |
Likely pathogenic |
— |
| RS2109021958 |
SEPSECS
|
Health Risk |
Likely pathogenic |
— |
| RS2109022156 |
SEPSECS
|
Health Risk |
Pathogenic |
— |
| RS2109022168 |
SEPSECS
|
Health Risk |
Pathogenic |
— |
| RS2109022340 |
SEPSECS
|
Health Risk |
Likely pathogenic |
— |
| RS2109022762 |
DVL3
|
Health Risk |
Likely pathogenic |
Autosomal dominant Robinow syndrome 3, Autosomal dominant Robinow syndrome 3 |
| RS2109023862 |
DVL3
|
Health Risk |
Likely pathogenic |
Autosomal dominant Robinow syndrome 3, Autosomal dominant Robinow syndrome 3 |
| RS2109023897 |
DVL3
|
Health Risk |
Likely pathogenic |
See cases, See cases |
| RS2109023958 |
CC2D2A
|
Health Risk |
Likely pathogenic |
— |
| RS2109029105 |
SEPSECS
|
Health Risk |
Likely pathogenic |
— |
| RS2109029810 |
CC2D2A
|
Health Risk |
Likely pathogenic |
Anencephaly, Polydactyly |
| RS2109029867 |
CC2D2A
|
Health Risk |
Pathogenic |
Meckel-Gruber syndrome, Joubert syndrome |
| RS2109032673 |
SEPSECS
|
Health Risk |
Pathogenic |
— |
| RS2109032716 |
SEPSECS
|
Health Risk |
Pathogenic |
— |
| RS2109034059 |
SEPSECS
|
Health Risk |
Pathogenic |
— |
| RS2109034069 |
SEPSECS
|
Health Risk |
Pathogenic |
— |
| RS2109034260 |
SEPSECS
|
Health Risk |
Likely pathogenic |
Pontocerebellar hypoplasia type 2D, Pontocerebellar hypoplasia type 2D |
| RS2109035117 |
NSD2
|
Health Risk |
Conflicting classifications of pathogenicity |
Rauch-Steindl syndrome, Rauch-Steindl syndrome |
| RS2109035570 |
SEPSECS
|
Health Risk |
Likely pathogenic |
— |
| RS2109035661 |
SEPSECS
|
Health Risk |
Pathogenic |
— |
| RS2109038924 |
SEPSECS
|
Health Risk |
Likely pathogenic |
— |
| RS2109039199 |
SEPSECS
|
Health Risk |
Pathogenic |
— |
| RS2109039412 |
OPA1
|
Health Risk |
Pathogenic |
— |
| RS2109039751 |
OPA1
|
Health Risk |
Pathogenic |
— |
| RS2109043623 |
OPA1
|
Health Risk |
Pathogenic |
— |
| RS2109043749 |
OPA1
|
Health Risk |
Pathogenic |
Autosomal dominant optic atrophy classic form, Optic atrophy |
| RS2109043753 |
OPA1
|
Health Risk |
Pathogenic |
— |
| RS2109043788 |
OPA1
|
Health Risk |
Likely pathogenic |
— |
| RS2109044278 |
OPA1
|
Health Risk |
Pathogenic |
— |
| RS2109044398 |
OPA1
|
Health Risk |
Pathogenic |
— |
| RS2109044547 |
OPA1
|
Health Risk |
Pathogenic |
— |
| RS2109047342 |
OPA1
|
Health Risk |
Pathogenic |
— |
| RS2109050324 |
CC2D2A
|
Health Risk |
Pathogenic |
Joubert syndrome 9, Joubert syndrome 9 |
| RS2109057310 |
SLC34A2
|
Health Risk |
Pathogenic |
— |
| RS2109057450 |
OPA1
|
Health Risk |
Pathogenic/Likely pathogenic |
— |
| RS2109058653 |
OPA1
|
Health Risk |
Pathogenic |
— |
| RS2109058910 |
OPA1
|
Health Risk |
Likely pathogenic |
Optic atrophy with or without deafness, ophthalmoplegia |
| RS2109058985 |
OPA1
|
Health Risk |
Likely pathogenic |
Optic atrophy with or without deafness, ophthalmoplegia |